Anfield Capital Management, LLC Novartis Ag Transaction History

Anfield Capital Management, LLC

  • $195 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021
SELL
$81.78 - $95.14 $37,618 - $43,764
-460 Closed
0 $0
Q2 2021

Aug 03, 2021
BUY
$85.24 - $94.15 $39,210 - $43,309
460 New
460 $42,000
Q1 2020

May 07, 2020
SELL
$70.67 - $99.01 $58,585 - $82,079
-829 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$84.35 - $95.37 $69,926 - $79,061
829 New
829 $80,000

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Anfield Capital Management, LLC Portfolio

Follow Anfield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anfield Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email